Featured Stories

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

Tentative Ohio Fracking Regulations Criticized as too Lax

Lawmakers in Ohio have tentatively passed new regulations governing hydraulic fracturing (fracking) drilling but they’ve immediately been criticized for being too favorable to the natural gas and oil industries.

Read More

Research Suggest Fracking Chemicals Can Pollute Aquifers

A new study suggests fluids used during the hydraulic fracturing (fracking) process could migrate through underground fractures and contaminate water aquifers.

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Increased Risk of Bone Fractures with Invokana and Invokamet XR

Despite a multitude of warnings for a drug taken for treatment of type 2 diabetes, the U.S. Food and Drug Administration (FDA) has expanded indications for Invokamet (canagliflozin and metformin). Invokamet along with Invokana (canagliflozin), carry warnings for adverse reactions including an increased risk for lower limb amputations, kidney failure, diabetic ketoacidosis, and cardiovascular injuries.

Invokamet was initially approved by the FDA in 2014. Invokamet XR was given the FDA’s green light as an extended-release drug for the treatment of type 2 diabetes. “Invokamet XR offers the convenience of once-daily dosing and provides physicians needed flexibility for tailoring treatment to the needs of type 2 diabetes patients, especially those with higher A1c levels,” said John Anderson, M.D., with the Frist Clinic in Nashville, Tennessee, in a published statement on behalf of Invokamet XR manufacturer Janssen Pharmaceuticals. Continue reading

Posted in Health Concerns, Pharmaceuticals |

Endo Agrees to Additional $775M Settlement for a Total of $2.6B

As of August 7, 2017, Endo International has agreed to set aside an additional $775 million to resolve the company’s remaining mesh lawsuits’ allegations related to the Transvaginal Mesh (TVM) Multidistrict (MDL) Litigation pending in the U.S. district Court of West Virginia. These claims involve Endo’s vaginal-mesh implants that allegedly eroded in some women, leaving them incontinent and in pain.

The agreement to fund settlement of the remaining 22,000 mesh suits notes the company has now set aside over $2.6 billion to finalize the litigation claims related to the American Medical Systems (AMS) faulty medical devices, according to document filed with the U.S. Securities and Exchange Commission (SEC). American Medical Systems, a subsidiary of Endo was sold to Boston Scientific in 2015. Continue reading

Posted in Defective Medical Devices, Defective Products, Health Concerns, Product Recalls, Recalled Vehicles, Transvaginal mesh |

General Motors Recalls 800,000 Trucks due to Power Steering Defects

Nearly 800,000 pickup trucks are being recalled by General Motors because they may suddenly lose power steering while the truck is being driven, and the sudden steering jolt may cause drivers to lose control of the vehicle, reports Fortune.

About 690,685 Chevy Silverado and GMC Sierra 1500s in the United States, as well as 80,000 in Canada and 25,000 in other counties are the pickups that have been affected. The Silverados were manufactured between January 30, 2013, and September 4, 2014, and the Sierras between January 29, 2013, and September 4, 2014, reports the Daily Hornet. Continue reading

Posted in Defective Products, Motor Vehicles, Product Recalls, Recalled Vehicles |

Mixed Metals are Focus of Stryker LFIT V40 Hip Implant Litigation

The Stryker Corporation is facing parallel litigations in Boston and New Jersey defending its LFIT Anatomic CoCr V40 Femoral Head (Cobalt Chromium V40) with allegations that the metal-on-metal ball and joint hip implant has a design defect causing it to fail prematurely. The giant medical device manufacturer sells its products worldwide in over 100 countries.

The alleged design defect is the junction between the femoral head and the femoral stem. The stems are normally titanium alloys and the heads are cobalt chromium and that is crux of the problem. Some hip implants of this type use a ceramic head. The current litigation revolves around the cobalt chromium heads combined with the titanium stems. It is alleged that the mixed metal can “fret” and corrode over time with everyday repetitive motion of the hip. Continue reading

Posted in Defective Medical Devices, Depuy, Health Concerns, Metal Hip Implants, Recalled Medical Devices |

Popular Heartburn Medications Linked to Increased Risk of Death

Drugs to relieve heartburn and acid-reflux are among the best selling drugs in the country, used by millions of Americans annually in both prescription and non-prescription strength.

Excess acid can cause stomach ulcers and damage to the esophagus. A reduction in stomach acid reduces irritation of the stomach lining and allows ulcers and irritation of the esophagus to heal, according to WebMD. Continue reading

Posted in Health Concerns, Pharmaceuticals, Proton Pump Inhibitors |

Stryker Hip Implant Failure Lawsuits Update

State-Based Stryker Lawsuits Consolidated in New Jersey

The New Jersey Supreme Court recently approved consolidation of all pending and future state-based hip replacement implant failure lawsuits brought against Stryker Corp. subsidiary, Howmedica Osteonics Corp.. within a multicounty legislation. The medical device products involved are the LFIT Anatomic Cobalt Chromium (CoCr) V40 femoral heads. The case is In re: Stryker LFIT Anatomic CoCr V40 Femoral Heads Litigation, Case No. 624, in the Superior Court of the State of New Jersey, County of Bergen.

The LFIT V40 Femoral Head is a hip replacement component that was recalled in 2016 over reports of taper lock failure. The alleged hip replacement implant failure involves corrosion at the point in which the head and neck intersect. The corrosion may cause the femoral head to break apart from the stem neck. This device failure would require immediate revision surgery. Continue reading

Posted in Defective Medical Devices, Metal Hip Implants |

Retired FDNY Firefighter Died Following Fight with 9/11-Related Cancer

Injured FDNY Member Fought Long and Hard for Zadroga Act and its Reauthorization

Ray Pfeifer, 59, a retired 27-year veteran of the Fire Department of New York (FDNY) died of cancer associated with his selfless work at the September 11th terrorist attacks in New York City. Pfeifer long fought his cancer that was attributed to his work at Ground Zero as he was also lobbying Congress to fund health care for his fellow first responders, officials said, Newsday reported.

Pfeifer worked approximately eight months on the pile of dangerous debris in lower Manhattan and also made more than one-dozen trips to Washington, D.C., to convince hesitant lawmakers to pass the James L. Zadroga 9/11 Health & Compensation Act. The Act is named to honor another 9/11 hero, a New York Police Department (NYPD) officer who died of respiratory disease contracted at Ground Zero, according to Newsday. Continue reading

Posted in Accident |

Takata Recalls an Additional 2.7 Million Air Bag Inflators

Takata has announced yet another air bag recall as part of the largest automotive recalls in United States history, this time involving 2.7 million air bag inflators made between 2005 and 2012. The cars involved are Ford, Nissan, and Mazda sold in the U.S. Some 42,000,000 vehicles are affected by the Takata air bag recalls as of January 19, 2017, according to the National Highway Traffic Safety Administration (NHTSA).

Reason for Current Recall

This most recent air bag inflator recall is triggered by test results that are foreseeing future air bag explosions, said the NHTSA in a statement. Takata reported that it is not aware of any ruptures having taken place, but is issuing the recall out of “an abundance of caution,” notes the NHTSA. This recall concerns the earliest generation of Takata airbag inflators, which use calcium sulfate as a desiccant (drying agent), and were put in driver-side airbags installed in vehicles sold by Mazda North American Operations, Nissan North America Inc., and Ford Motor Co., reports the NHTSA. Continue reading

Posted in Defective Products, Motor Vehicles |

Soliris Vaccination Raises Risk for Meningococcal Disease

People who have received eculizumab (brand name Soliris) are at high risk (1,000 to 2,000-fold greater), for invasive meningococcal disease compared to the general United States population. Life-threatening and fatal infections have occurred in some patients treated with Soliris. These infections may become rapidly deadly if not recognized and treated promptly, according to RxList.

What is Soliris?

Soliris is used to treat two rare blood disorders, paroxysmal nocturnal hemoglobinuria (PNH) that can cause a decrease in red blood cells (anemia). Soliris helps to block the decrease in red blood cells and can improve the symptoms of anemia such as tiredness, shortness of breath, and can decrease the need for blood transfusions. Continue reading

Posted in Health Concerns, Pharmaceuticals |

Oscor Recalls Defective Cables for External Pacemakers and Diagnostic Machines

On July 6, 2017, Oscor, Inc. issued a nationwide recall of Atar Reusable Extension Cables and Atar Disposable Extension Cables, which connect to external cardiac pacemakers or diagnostic machines.

During use, some Atar extension cables separated from the connector at the proximal end (the end nearer to the center of the body), the U.S. Food and Drug Administration (FDA) reports. Continue reading

Posted in Defective Medical Devices |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.